Sanità internazionale 11 Ottobre 2016 15:33

No study grants for doctors in training: physicians on a war footing… en France

11 months waiting for study grants but they have not arrived yet. The young doctors studying for specialisation in France could be obliged to leave their training courses. They are deceived by the authorities: “We relied on those grants in order to pay the inscription”, the doctors say.   If the grants are not given […]

11 months waiting for study grants but they have not arrived yet. The young doctors studying for specialisation in France could be obliged to leave their training courses. They are deceived by the authorities: “We relied on those grants in order to pay the inscription”, the doctors say.

 

If the grants are not given this year, many physicians will be obliged to annul the enrollments because of the impossibility to pay. This is in contrast with the Government policy, whose purpose was to give to the country highly qualified healthcare professionals. Since the deficit of specialised doctors increases more and more, the Health Ministry had decided to give grants to physicians in order to give them the possibility to attend specialisation training: in 2014 every enrolled physician received a study grant. Aware of this possibility, the young doctors left their previous contract to start the specialisation.

GLI ARTICOLI PIU’ LETTI
Advocacy e Associazioni

Porpora trombotica trombocitopenica. ANPTT Onlus celebra la III Giornata nazionale

Evento “WeHealth” promosso in partnership con Sanofi e in collaborazione con Sics Editore per alzare l’attenzione sulla porpora trombotica trombocitopenica (TTP) e i bisogni ancora i...
Salute

Tumori: boom di casi nei paesi occidentali. Cinieri (Aiom): “Prevenzione attiva per ridurre carico della malattia”

Nel 2024 negli USA, per la prima volta nella storia, si supera la soglia di 2 milioni di casi di tumore. Una crescita importante, comune a tutti i Paesi occidentali. Per Saverio Cinieri, presidente di...
Salute

Tumore del polmone non a piccole cellule di stadio precoce e avanzato: lo stato dell’arte di nivolumab

Sono stati presentati al recente Congresso ASCO gli aggiornamenti degli studi relativi all’impiego di nivolumab nel tumore del polmone non a piccole cellule di stadio precoce e avanzato. Il quad...
Advocacy e Associazioni

Cirrosi epatica, i pazienti chiedono meno burocrazia e maggior accesso al teleconsulto

Nella nuova puntata di The Patient Voice, Ivan Gardini (EpaC Ets), Ilenia Malavasi (Affari Sociali) e Francesca Ponziani (Pol. Gemelli)